Press Releases Archives - Page 28 of 103 - Lupin

BSE 2308.00 NSE 2305.20

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2308.00 NSE 2305.20

Lupin Diagnostics Expands its Footprint in Central India; Launches Regional Reference Laboratory in Indore

December 21, 2022

Lupin Receives Approval from U.S. FDA for Brivaracetam Tablets

December 21, 2022

Lupin Launches Authorized Generic Version of PENNSAID® 2% w/w in the United States

December 9, 2022

Lupin Appoints Spiro Gavaris as President of U.S. Generics Business

December 8, 2022

Lupin Launches Rufinamide Tablets USP in the United States

December 5, 2022

Lupin Launches Formoterol Fumarate Inhalation Solution in the United States

November 29, 2022

Lupin’s Brazilian Subsidiary, MedQuimica Acquires Rights to Nine Brands from Bausch Health

November 28, 2022

Lupin Signs MoU with the Government of Rajasthan to strengthen Healthcare system

November 21, 2022

Luforbec® 200/6 (beclometasone 200mcg / formoterol 6mcg) a certified carbon neutral inhaler is launched in the UK for the treatment of adult asthma^1,2,3

November 14, 2022

Lupin Q2 FY2023 Results

November 9, 2022

1 2 … 27 28 29 … 102 103

Search

Hit enter to search or ESC to close